Suspected unexpected adverse effect of sugammadex: hypotension

European Journal of Clinical Pharmacology - Tập 68 - Trang 899-900 - 2011
Merja Kokki1, Mohamed Ali1, Matti Turunen1, Hannu Kokki1,2
1Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, School of Medicine, University of Eastern Finland, Kuopio, Finland
2Department of Anaesthesiology and Operative Services, Kuopio University Hospital, Kuopio, Finland

Tài liệu tham khảo

Loftsson T, Jarho P, Másson M, Järvinen T (2005) Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2:335–251 European Medicines Agency. Assessment report for Bridion. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000885/WC500052309.pdf. Accessed 20 June 2011 Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J (2006) Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 104:667–674 Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, Viars P (1994) Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81:299–307 Aronson S, Dyke CM, Levy JH, Cheung AT, Lumb PD, Avery EG, Hu MY, Newman MF (2011) Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials. Anesth Analg 113:19–30